Shin-Etsu Chemical (4063) Q4 2026 earnings summary

Executive summary

• Net sales rose 0.5% year-over-year to ¥2,573.9 billion, while operating income fell 14% to ¥635.2 billion and net income attributable to owners of parent declined 11% to ¥474.4 billion.

• Results aligned with prior forecasts despite global economic headwinds, including U.S. policy shifts, persistent Chinese oversupply, and the outbreak of war in the Middle East.

• Focus remains on business growth, product development for AI and semiconductors, and continued capital investment.

Financial highlights

• Operating income margin decreased to 24.7% from 29.0% year-over-year.

• ROE dropped to 10.4% from 12.0%; ROIC fell to 14.6% from 18.2%.

• Cash and cash equivalents at year-end decreased 36% to ¥562.0 billion, mainly due to share repurchases and capital investments.

• Dividend payout ratio increased to 41.9% (annual dividend maintained at ¥106 per share).

Outlook and guidance

• No forecast for FY2027 due to uncertainty from energy/raw material price fluctuations and geopolitical risks.

• Management targets continued annual revenue and earnings growth, with a focus on resilience and agility in response to market changes.